Man Nie

7PUBLICATIONS

55CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Autoimmunity

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Jun 15, 2026

Liposomal mitoxantrone plus tislelizumab in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma: a phase 1b/2 trial.

|Jun 10, 2026

TQB2618 plus penpulimab, alone or in combination with chemotherapy, for recurrent or metastatic nasopharyngeal carcinoma: a multicentre, two-cohort, phase 2 trial.

|Mar 30, 2026

LM-101, an Anti-SIRPα Antibody, in Patients with Relapsed/Refractory Lymphoma and Advanced Head and Neck Cancer: An Open-Label, Multicenter, Phase I Trial.

Jun Cai, Baitian Zhao, Dongmei Ji

|Mar 28, 2026

Zanubrutinib-rituximab followed by shortened chemoimmunotherapy as frontline treatment for mantle cell lymphoma (CHESS): a phase II trial.

Yuchen Zhang, Man Nie, Yi Cao

|Feb 25, 2026

Prostaglandin E<sub>2</sub> induces dendritic cell dysfunction in skin involvement of breast cancer.

Jiawen Wang, Xiaoming Zhong, Xu Liu

|May 29, 2025

Cardiomyocyte-localized CCDC25 senses NET DNA to promote doxorubicin cardiotoxicity by activating autophagic flux.

Man Nie, Dexin Lei, Zhou Liu

Pageof 2

Frequent Collaborators

Yi Xia

Qingqing Cai

Panpan Liu

Yuchen Zhang

Zhiming Li

Jun Cai

Huiqiang Huang

Wei Zhang

Peng Huang

Erwei Song

Frequent Collaborators

Yi Xia

Qingqing Cai

Panpan Liu

Yuchen Zhang